RECENT NEWS

London-based pathology services partnership Synnovis has issued a further update following the recent cyberattack, confirming that patient information published online was stolen from its systems.

Bio-Rad Laboratories has launched four new anti-idiotypic antibodies to the following drugs: atezolizumab (Tecentriq), avelumab (Bavencio), obinutuzumab (Gazyvaro), and ocrelizumab (Ocrevus), extending its range of anti-biotherapeutic antibodies. The company also introduced its anti-monomethyl auristatin E (MMAE) biotherapeutic antibody range for bioanalysis.

BIOHIT HealthCare is excited to announce an upcoming webinar, 'Current and future trends in inflammatory bowel disease (IBD) therapeutic drug monitoring (TDM)', which will take place on 3 July at 12:30-1:30pm BST.

A low-cost CRISPR-based paper-strip test distinguishes between influenza types and can be reprogrammed to recognise different viruses including H5N1 bird influenza. A recently published paper describes the development of the new test that could allow more patients to find out which type of influenza they have and get the right treatment.

The Royal College of Pathologists (RCPath) has announced the winners of its Achievement Awards. Six RCPath Achievement Awards were presented this year, four 'Team' awards and two awards for in the new category of 'Sustainability'.

Following five popular meetings, Cardiac Marker Dialogues is pleased to be back with an exciting programme for a sixth meeting in Glasgow in September 2024.

Roche has launched new analytical units, cobas c 703 and cobas ISE neo, for the cobas pro integrated solutions, in countries accepting the CE mark. The cobas pro integrated solutions is a scalable and modular diagnostic platform designed for high-volume laboratories.

NHS trusts are determined to do everything they can to help health services to be even more productive but need support from government and national bodies to unlock their full potential for improvement, a new report from NHS Providers says.

Bio-Rad Laboratories has announced the launch of the ddSEQ Single-Cell 3' RNA-Seq Kit and complementary Omnition v1.1 analysis software for single-cell transcriptome and gene expression research.

Roche has announced the launch of the first clinically approved highly sensitive in situ hybridisation (ISH) test, the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, in countries accepting the CE Mark. The test is designed to help pathologists differentiate a B-cell malignancy from a normal, reactive response to an infection.

Registration is open now for The Power to Disrupt - Clinical Diagnostics Expo UK, the ninth face-to-face event provided by Thornhill Healthcare Events in partnership with POCTInnovators.com. Taking place in London during September, Pathology in Practice will be supporting the event with a special supplement.

BIVDA continues to strengthen its team, welcoming Beth Loudon as Head of Market Access from September 2024. Beth is currently the Medical and Surgical Consumables Director for NHS Supply Chain, leading the clinical and commercial team responsible for assurance of value and resilience for the supply of clinical goods to the NHS.

The effects of the recent cyber attack on pathology services provider Synnovis could last for ‘months’ an NHS update has revealed. The clinical impact of the attack has seen a significant reduction in the number of tests which can be processed and reported back to clinical teams at Guy’s and St Thomas’ NHS Foundation Trust and King’s College Hospitals NHS Trust.

Roche has announced that its whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), has received 510(k) clearance from the US Food and Drug Administration (FDA). The system is intended to aid the pathologist in reviewing and interpreting digital images of scanned pathology slides, and assist diagnosis.

The Science Council has announced that David Wells CSci, Chief Executive of the Institute of Biomedical Science (IBMS), has been appointed as the new Chair of its Board of Trustees. David, who has been a trustee of the Science Council since 2022, will succeed Adam Donnan in September 2024.

Beckman Coulter Life Sciences has launched its Biomek Echo One System, which aims to accelerate high-throughput genomic sample preparation workflows to deliver results faster.

Northern Ireland’s CoreLIMS programme has achieved another significant milestone by migrating the Northern Ireland Blood Transfusion Service (NIBTS) away from its 15-year-old laboratory information system and onto Clinisys WinPath.

Non-governmental organisation The Foundation for Innovative New Diagnostics (FIND) and the World Health Organization (WHO) have signed a new Memorandum of Understanding that lays the foundation for accelerating innovation and achieving equitable access to quality diagnostics for people globally.

Leica Biosystems and Navinci, a leader in developing innovative solutions for studying protein interactions, have announced a strategic collaboration to drive innovation in cancer patient care. This partnership enables automated in situ proximity ligation assays on the BOND RX Fully Automated Research Stainer.

A new Community Diagnostic Centre (CDC) has been completed by MTX at Clatterbridge Hospital on Merseyside using modern methods of construction to deliver the project faster, greener, safer and more cost effectively.